| Literature DB >> 30740256 |
Natalia L Calvo1,2, Vera A Alvarez3, María C Lamas1,4, Darío Leonardi1,4.
Abstract
Tioconazole (TCZ), a broad-spectrum antifungal agent, has significant activity against Candida albicans and other Candida species, and therefore, it is indicated for the topical treatment of superficial mycoses. The main goal of this work is to report an exhaustive identification and characterization procedure to improve and facilitate the online quality control and continuous process monitoring of TCZ in bulk material and loaded in two different dosage forms: ovules and nail lacquer. The methodologies were based on thermal (differential scanning calorimetry (DSC), melting point, and thermogravimetry (TG)), spectroscopic (ultraviolet (UV), Raman, near infrared (NIR), infrared spectroscopy coupled to attenuated total reflectance (FTIR-ATR), and nuclear magnetic resonance (NMR)), microscopic and X-ray diffraction (XRD). The TCZ bulk powder showed a high crystallinity, as observed by XRD, with a particles size distribution (3-95 µm) resolved by microscopic measurements. TCZ melting point (82.8 °C) and a degradation peak centered at 297.8 °C were obtained by DSC and DTG, respectively. An unambiguous structure elucidation of TCZ was obtained by mono- and two- dimensional 1H and 13C NMR spectral data analysis. The FTIR-ATR, Raman and NIR spectra of both the raw material and the commercial products were analyzed and their characteristic bands were tabulated. The best methods for TCZ identification in ovules were DSC, TG, XRD, NIR and Raman, while NIR and FTIR-ATR were the most appropriate techniques to analyze it in the nail lacquer. DSC, TG, DRX, Raman, FTIR-ATR and NIR spectroscopy are effective techniques to be used in online process analysis, because they do not require sample preparation, and they are considerably sensitive to analyze complex samples.Entities:
Keywords: Characterization; Identification; Pharmaceutical dosage forms; Spectroscopic methods; Tioconazole
Year: 2018 PMID: 30740256 PMCID: PMC6355464 DOI: 10.1016/j.jpha.2018.11.006
Source DB: PubMed Journal: J Pharm Anal ISSN: 2214-0883
Fig. 1Thermograms of TCZ. (A) DSC and (B) TG and DTG.
Fig. 2(A) FTIR-ATR, (B) NIR and (C) Raman spectra of TCZ bulk drug.
Fig. 3Crystanillity, particle size and morphology of TCZ. (A) XRD powder pattern. SEM micrographs at (B) 200×, (C) 1000×, and (D) 5000× magnifications.
Fig. 4NMR 13C (16 peaks) and DEPT 135 spectrum (11 peaks).
Fig. 51H NMR spectra of TCZ.
Fig. 62D HSQC spectra. (A) Pure shift HSQC spectrum in the region of 48–79/5.1–4.1 ppm. (B) Pure shift HSQC (blue) and HSQC (red) in the region of 119–139/7.7–6.8 ppm.
NMR signal assignments (H and C) of TCZ, employing 1D (1H, 13C and DEPT 135) and 2D (HSQC, HMBC and COSY) experiments.
| H | C | 1H (ppm) | 13C (ppm) | HSQC | HMBC | COSY | |
|---|---|---|---|---|---|---|---|
| a | 1 | 7.47–7.43 (1H, m) | 137.76 (CH, sp2) | + | C2; C3 | Hc; Hd | |
| b | 2 | 6.83 (1H, t) | 1.1 | 128.18 (CH, sp2) | + | C1; C3 | Hc |
| c | 3 | 7.00 (1H, t) | 1.1 | 119.88 (CH, sp2) | + | C1; C2; C4 | Ha; Hb; Hd |
| d | 4 | 4.24–4.19 (2H, m) | 50.00 (CH2, sp3) | + | C1; C3; C5; C6 | Ha; Hc; He | |
| e | 5 | 4.96 (1H, dd) | 4.1 | 76.39 (CH, sp3) | + | C4; C6; C7; C11; C12 | Hd; Hh; Hi; Hi |
| 6.7 | |||||||
| 6 | 134.67 (C, sp2) | ||||||
| 7 | 133.14 (C, sp2) | ||||||
| f | 8 | 7.64 (1H, d) | 2.1 | 128.91 (CH, sp2) | + | C6; C7; C9; C10 | Hg |
| 9 | 133.49 (C, sp2) | ||||||
| g | 10 | 7.47–7.43 (1H, m) | 2.2 | 127.78 (CH, sp2) | + | C6; C8 | Hf; Hh |
| 8.1 | |||||||
| h | 11 | 7.36 (1H, d) | 8.4 | 129.29 (CH, sp2) | + | C5; C7; C9 | Hg |
| i | 12 | 4.26 (1H, d) | 11.9 | 63.22 (CH2, sp3) | + | C5; C13; C14; C16 | He; Hj |
| i | 12 | 4.33 (1H, d) | 11.9 | 63.22 (CH2, sp3) | + | C5; C13; C14; C16 | Hj |
| 13 | 126.34(C, sp2) | ||||||
| j | 14 | 6.84 (1H, d) | 5.7 | 127.89 (CH, sp2) | + | C12; C13; C15; C16 | Hi; Hk |
| k | 15 | 7.39 (1H, d) | 5.7 | 124.52 (CH, sp2) | + | C13; C14; C16 | Hj |
| 16 | 134.73(C, sp2) |
The + sign indicates that a cross-peak was observed.
Carbon atoms exhibing cross-peaks with the observed H-atom.
Hydrogen atoms exhibing cross-peaks with the observed H-atom.
Hydrogen not equivalent.
TCZ spectroscopic data on bulk raw material and commercial products.
| Technique | TCZ | Ovule | Nail lacquer |
|---|---|---|---|
| NIR (nm) | 1394.5 | 1392.5 | 1387.0 |
| 1634.0 | 1634.0 | 1635.0 | |
| 1683.0 | – | 1681.5 | |
| 1717.5 | 1726.5 | 1723.0 | |
| 1760.5 | 1761.5 | 1758.0 | |
| 1816.5 | 1816.5 | – | |
| 2152.5 | 2153.0 | – | |
| 2200.0 | 2200.0 | – | |
| 2304.5 | 2311.0 | 2305.0 | |
| FTIR-ATR (cm | – | 721.4 | – |
| 626.8 | – | 626.8 | |
| 657.7 | – | 657.7 | |
| 690.5 | – | 690.5 | |
| 733.0 | 733.0 | – | |
| 993.3 | – | 993.3 | |
| 1336.7 | 1338.6 | 1336.7 | |
| 1371.4 | 1375.3 | 1371.4 | |
| 1454.3 | 1456.5 | 1454.3 | |
| 1464.0 | – | 1467.8 | |
| 1562.3 | – | 1562.3 | |
| 1587.4 | – | 1589.3 | |
| – | 2848.9 | 2852.7 | |
| – | 2918.3 | 2924.1 | |
| Raman (cm | 251.6 | 251.6 | – |
| 265.8 | 265.8 | – | |
| 287.0 | 287.0 | – | |
| – | – | 382.4 | |
| 450.5 | 450.5 | – | |
| 517.4 | 517.4 | – | |
| 593.7 | 593.7 | – | |
| – | – | 634.5 | |
| 666.3 | 666.3 | – | |
| 693.6 | 693.6 | – | |
| 833.0 | 831.0 | – | |
| – | – | 848.9 | |
| 1068.3 | 1068.3 | – | |
| 1088.7 | 1088.7 | – |
Signals corresponding to a shoulder.
Fig. 7DSC thermograms of (A) TCZ, and pharmaceutical dosage forms: (B) ovule and (C) nail lacquer.
Fig. 8XRD pattern of (A) nail lacquer, (B) ovule, and (C) TCZ.
Fig. 9TG and DTG curves of (A) nail lacquer and (B) ovule.